pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,702 catalysts · 5,443 phase readout · 2,304 8k filing · 343 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 33 catalysts2026-08-04: 13 catalysts2026-08-05: 18 catalysts2026-08-06: 11 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 1 catalyst2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 0 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: filing×type: phase readout×clear all
type
  • phase readout5,443
  • 8k filing2,304
  • pdufa343
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07404423: OPEN-IPF: Observational Prediction modEl for cliNical Outcomes in Idiopathic Pulmonary Fibrosis

Sponsor: University of Modena and Reggio Emilia. Phase: . Conditions: Idiopathic Pulmonary Fibrosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07559123: Imaging-based PRediction of Eligibility for ChemoImmunotherapy in reSEctable NSCLC, iPRECISE

Sponsor: Samsung Medical Center. Phase: . Conditions: NSCLC, Neoadjuvant Chemoimmunotherapy, CT

full page →ctgov ↗
›COMPLETEDphase readoutNCT03899259: A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Alopecia Areata

full page →ctgov ↗
›RECRUITINGphase readoutNCT06773780: Transcatheter Aortic Valve Implantation: Comparison of the Effects of Ultrasound-Guided Pericapsular Nerve Group Block and Fascia Iliaca Block on Postoperative Analgesia Management

Sponsor: Medipol University. Phase: NA. Conditions: Aortic Valve Stenosis, Transcatheter Aortic Valve Implantation, Pericapsular Nerve Group Block, Fascia Iliaca Block

full page →ctgov ↗
›RECRUITINGphase readoutNCT06721455: Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery

Sponsor: Boston Children's Hospital. Phase: . Conditions: Heart Surgery, Blood Transfusion, Hemolysis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05339555: IUD Self-Removal Study

Sponsor: Oregon Health and Science University. Phase: NA. Conditions: IUD

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07644455: Percutaneous Biopsy After Neoadjuvant Chemotherapy.

Sponsor: Instituto do Cancer do Estado de São Paulo. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06260878: Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis

Sponsor: University of Calgary. Phase: PHASE4. Conditions: Post-ERCP Acute Pancreatitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05960578: Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study

Sponsor: University of Washington. Phase: PHASE2. Conditions: Metastatic Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8

full page →ctgov ↗
›RECRUITINGphase readoutNCT07631078: kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery (KULMINATE) Pilot

Sponsor: Magnetic Tides. Phase: NA. Conditions: Stroke, Chronic Stroke Patients, Arm Weakness as a Consequence of Stroke

full page →ctgov ↗
›COMPLETEDphase readoutNCT00611585: A Safety and Efficacy Study of the Birmingham Hip Resurfacing System

Sponsor: Smith & Nephew, Inc.. Phase: . Conditions: Arthritis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04163185: Initiating Early Control of Migraine Pain and Associated Symptoms

Sponsor: Axsome Therapeutics, Inc.. Phase: PHASE3. Conditions: Migraine

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03772743: Functional Assessment in Elderly MI Patients With Multivessel Disease

Sponsor: Consorzio Futuro in Ricerca. Phase: NA. Conditions: Myocardial Infarction

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04200443: Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Sponsor: City of Hope Medical Center. Phase: PHASE2. Conditions: Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8, Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8, Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8, Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8, Stage IV Uterine Corpus Leiomyosarcoma AJCC v8, Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8, Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8, Unresectable Leiomyosarcoma, Unresectable Soft Tissue Sarcoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07352215: PRP Plus Fractional CO₂ Laser for Acne Scars

Sponsor: Gujranwala medical college District Headquarters Hospital, Gujranwala. Phase: NA. Conditions: Post-Acne Atrophic Scars, Carbon Dioxide Lasers, Platelet-Rich Plasma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06950515: General Anesthesia vs Conscious Sedation for Radial Endobronchial Ultrasound

Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval. Phase: NA. Conditions: Lung Cancers, Peripheral Pulmonary Nodules

full page →ctgov ↗
›RECRUITINGphase readoutNCT06626425: Well-being Training for Adolescent Depressive Symptoms (TeenWell Study)

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Depression

full page →ctgov ↗
›COMPLETEDphase readoutNCT07400276: Ayurveda Diet & Lifestyle Protocol for Type 2 Diabetes: A Feasibility Study

Sponsor: Maharishi International University. Phase: NA. Conditions: Type 2 Diabetes Mellitus (T2DM)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07114276: Prospective Validation of Machine Learning Model to Predict Platinum Induced Nephrotoxicity in Cancer Patients

Sponsor: Taipei Medical University. Phase: . Conditions: Chemotherapy Side Effects, Machine Learning, Acute Kidney Injury, Acute Kidney Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07494825: CIED Post-OR Rehabilitation

Sponsor: Shanghai Zhongshan Hospital. Phase: NA. Conditions: CIED Postoperative Upper Limb Stiffness and Disability

full page →ctgov ↗
›RECRUITINGphase readoutNCT07627217: MNGIE Natural History Study

Sponsor: University of Cambridge. Phase: . Conditions: MNGIE, Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)

full page →ctgov ↗
›COMPLETEDphase readoutNCT03659968: Initiation of Adapted Physical Activity for Patients With Advanced Pediatric Malignancies

Sponsor: Assistance Publique Hopitaux De Marseille. Phase: NA. Conditions: Pediatric Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07304050: Predicting ICU Transfers and Other Unforeseen Events (PICTURE)-Pediatric

Sponsor: University of Michigan. Phase: NA. Conditions: Clinical Deterioration

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07037550: Effectiveness of Strength-based Intervention for Elderly With Dementia Living in the Community

Sponsor: The University of Hong Kong. Phase: NA. Conditions: Dementia, Mild Cognitive Impairment, Caregiver, Dementia Alzheimer Type

full page →ctgov ↗
›RECRUITINGphase readoutNCT04585750: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Sponsor: PMV Pharmaceuticals, Inc. Phase: PHASE1. Conditions: Advanced Solid Tumor, Advanced Malignant Neoplasm, Metastatic Cancer, Metastatic Solid Tumor, Lung Cancer, Ovarian Cancer, Endometrial Cancer, Prostate Cancer, Colorectal Cancer, Breast Cancer, Other Cancer, Locally Advanced, Head and Neck Cancer, Gall Bladder Cancer, Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Small Cell Lung Carcinoma, NSCLC, NSCLC (Non-small Cell Lung Cancer), SCLC, Non-Small Cell Lung Carcinoma, Triple Negative Breast Cancer, TNBC, HER2+ Breast Cancer, Non-Small Cell Lung Cancer, ER/PR Positive Breast Cancer, HER2- Breast Cancer, HER2-positive Breast Cancer, HER2-negative Breast Cancer, ER/PR(+), Her2(-) Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07403591: Mapsd Dual-target cTBS (Auditory Cortex and M1) for Generalized Anxiety Disorder

Sponsor: Anhui Medical University. Phase: NA. Conditions: Generalized Anxiety Disorder

full page →ctgov ↗
›WITHHELDphase readoutNCT06857591: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›COMPLETEDphase readoutNCT06501274: Capsule Sponge Study in Eosinophilic Oesophagitis

Sponsor: East and North Hertfordshire NHS Trust. Phase: NA. Conditions: Eosinophilic Esophagitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05782374: Real World Data on Ibrutinib Use in PCNSL Rel/Ref

Sponsor: IRCCS San Raffaele. Phase: . Conditions: PCNSL

full page →ctgov ↗
›RECRUITINGphase readoutNCT06008197: A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Sponsor: Colorado Prevention Center. Phase: PHASE3. Conditions: Heart Failure, Acute Heart Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07422597: Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate Cancer

Sponsor: Norwegian University of Science and Technology. Phase: NA. Conditions: Prostate Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04041310: Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

Sponsor: Nouscom SRL. Phase: PHASE1. Conditions: Solid Tumor, Adult

full page →ctgov ↗
›RECRUITINGphase readoutNCT01762813: Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer

Sponsor: Helse Stavanger HF. Phase: . Conditions: Colorectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07417813: A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders

Sponsor: Shanghai Mental Health Center. Phase: . Conditions: Insomnia, Psychiatric Disorders

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07503613: Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy

Sponsor: Akouos, Inc.. Phase: . Conditions: Vestibular Schwannoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05764213: Improving Maternal Mental Health & SUD Screening and Treatment

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Mental Health Issue, Substance Use Disorders, Postpartum Depression, Postpartum Anxiety

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07545213: Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis

Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Phase: PHASE2. Conditions: Non-small Cell Lung Cancer, EGFR Mutant Advanced Non-small Cell Lung Cancer

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06874413: Targeted Prehabilitation With Physical Exercise and Inspiratory Muscle Training for Elderly Frail Patients Prior to Ventral Hernia Repair

Sponsor: Prisma Health-Upstate. Phase: NA. Conditions: Frailty, Ventral Hernia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07477613: Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke

Sponsor: University Hospital, Grenoble. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06652620: Cola Ingestion for Esophageal Bolus Impaction

Sponsor: Fudan University. Phase: NA. Conditions: Esophageal Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07378982: 3D Printed Ceramic-Filled Photopolymer Resin Vs. CAD/CAM Resin Composite Overlays for Restoration of Extensively Damaged Endodontically Treated Posterior Teeth. An 18-month Follow-up

Sponsor: Cairo University. Phase: NA. Conditions: Endodontically Treated Molar, Dental Restoration, Permanent

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03241420: Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease

Sponsor: National Jewish Health. Phase: . Conditions: Chronic Lung Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06047782: Impact of Atrial Fibrosis Surface Area on the Occurrence of Atrial Fibrillation in Patients With Ischemic Stroke of Undetermined Origin: a Prospective Cardiac MRI Pilot Study.

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: NA. Conditions: Stroke, Implantation of an Implantable Cardiac Monitor

full page →ctgov ↗
›RECRUITINGphase readoutNCT07159282: A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers

Sponsor: Applied Biologics, LLC. Phase: PHASE4. Conditions: Diabetic Foot, Foot Ulcer, Ulcer Foot, DFU, Foot Ulcer Due to Type 2 Diabetes Mellitus, Foot Ulcer Due to Type 1 Diabetes Mellitus, Diabetic Foot Ulcer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07650682: Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes

Sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology. Phase: . Conditions: Type 2 Diabetes, Insulin Dependent Diabetes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07301424: Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

Sponsor: University of Alberta. Phase: PHASE2. Conditions: Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+), BCR-ABL Positive Acute Lymphoblastic Leukemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT07434323: Lavender Aromatherapy for Preoperative Anxiety in Melanoma and Epithelioma Patients

Sponsor: San Gallicano Dermatological Institute IRCCS. Phase: NA. Conditions: Melanoma, Non-Melanoma Skin Cancer, Preoperative Anxiety, pT1a

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05863923: Tobacco Cessation Texting Intervention for People Living With HIV Who Smoke in Vietnam

Sponsor: University of Massachusetts, Worcester. Phase: NA. Conditions: Tobacco Cessation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06485323: MRI Pseudo-CT Sequences for Obstetrical Pelvimetry.

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Phase: NA. Conditions: Obstetric Labor Complications

full page →ctgov ↗
›COMPLETEDphase readoutNCT04095923: A Social Media Game to Increase Physical Activity Among Older Adult Women

Sponsor: The University of Texas Medical Branch, Galveston. Phase: NA. Conditions: Aging

full page →ctgov ↗
← prev
page 114 of 115
next →